Nextgen Group Plc
LONDON and ANN ARBOR, Michigan, June 21, 2011 -
NextGen Group plc (AIM:NGG) is pleased to announce that its
US-subsidiary NextGen Sciences Inc, a leader in biomarker
discovery, measurement and qualification, has launched its first cerebrospinal
fluid (CSF) multiple protein (multiplex) assay,
csfdiscovery43, for central nervous system (CNS) biomarker
discovery and qualification.
ANN ARBOR, Michigan and LONDON, March 16, 2011 - NextGen Group plc (AIM:NGG) is pleased to announce that its
subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement
and qualification, has launched its first multiple protein (multiplex) assay,
plasmadiscovery41, for oncology biomarker discovery and qualification.
ANN ARBOR, Michigan, and LONDON, March 9, 2011 - NextGen Group plc (AIM:NGG) is pleased to announce that its
subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement
and qualification, has completed a commercial reorganization.
